Total Payments
$1,734
2023 Payments
$355.60
Companies
29
Transactions
96
Medicare Patients
1,154
Medicare Billing
$171,016
Payment Breakdown by Category
Food & Beverage$1,710 (98.6%)
Education$23.92 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,710 | 94 | 98.6% |
| Education | $23.92 | 2 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $214.64 | 14 | $0 (2022) |
| Veran Medical Technologies, Inc. | $198.12 | 3 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $165.60 | 10 | $0 (2023) |
| Merck Sharp & Dohme LLC | $145.31 | 8 | $0 (2022) |
| Janssen Biotech, Inc. | $87.73 | 5 | $0 (2023) |
| Novocure Inc. | $82.36 | 1 | $0 (2017) |
| PFIZER INC. | $81.91 | 7 | $0 (2023) |
| GENZYME CORPORATION | $74.25 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $74.16 | 6 | $0 (2021) |
| Gilead Sciences, Inc. | $73.46 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $355.60 | 19 | GENZYME CORPORATION ($47.62) |
| 2022 | $339.03 | 20 | Amgen Inc. ($50.85) |
| 2021 | $267.86 | 18 | Novartis Pharmaceuticals Corporation ($48.91) |
| 2020 | $11.91 | 1 | Astellas Pharma US Inc ($11.91) |
| 2019 | $183.41 | 11 | Amgen Inc. ($50.61) |
| 2018 | $201.95 | 8 | Veran Medical Technologies, Inc. ($116.06) |
| 2017 | $374.46 | 19 | Novocure Inc. ($82.36) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/29/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Oncology | ||||||
| 07/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ONCOLOGY | ||||||
| 07/08/2022 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Hematology | ||||||
| 07/01/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 05/27/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Oncology | ||||||
| 05/20/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Oncology | ||||||
| 05/06/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Oncology | ||||||
| 04/29/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ONCOLOGY | ||||||
| 04/22/2022 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2022 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO, LIBTAYO | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Oncology | ||||||
| 03/25/2022 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 01/21/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ONCOLOGY | ||||||
| 01/07/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Oncology | ||||||
| 12/17/2021 | Janssen Biotech, Inc. | RYBREVANT (Drug), ERLEADA | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 12/02/2021 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 11/12/2021 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Hematology | ||||||
| 11/05/2021 | Rigel Pharmaceuticals, Inc. | Tavalisse (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Hematology | ||||||
| 10/29/2021 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2021 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), FEMARA, PIQRAY | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Bone Health | ||||||
| 08/06/2021 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Oncology | ||||||
| 07/16/2021 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.70 | General |
| Category: Cardiovascular | ||||||
| 06/18/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 267 | 597 | $138,499 | $41,032 |
| 2022 | 5 | 263 | 558 | $95,298 | $37,470 |
| 2021 | 6 | 329 | 739 | $130,818 | $51,963 |
| 2020 | 5 | 295 | 695 | $123,488 | $40,552 |
Total Patients
1,154
Total Services
2,589
Medicare Billing
$171,016
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 463 | $111,523 | $32,804 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 45 | $7,023 | $2,256 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 35 | $7,167 | $2,096 | 29.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $5,358 | $1,623 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,048 | $1,244 | 30.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 26 | $3,380 | $1,009 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 447 | $78,225 | $31,316 | 40.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $5,780 | $2,106 | 36.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 33 | $5,379 | $1,816 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 30 | $3,450 | $1,455 | 42.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 28 | $2,464 | $776.08 | 31.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 561 | $98,175 | $40,376 | 41.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 62 | $10,106 | $3,425 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $9,013 | $3,251 | 36.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 25 | $7,650 | $2,655 | 34.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 38 | $3,344 | $1,141 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $2,530 | $1,115 | 44.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 204 | 560 | $98,000 | $31,878 | 32.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 66 | $10,758 | $3,782 | 35.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 21 | $6,426 | $2,288 | 35.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $4,624 | $1,647 | 35.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 32 | $3,680 | $957.06 | 26.0% |
About Dr. Brian Gaupp, M.D
Dr. Brian Gaupp, M.D is a Hematology & Oncology healthcare provider based in Thomasville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649265430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Gaupp, M.D has received a total of $1,734 in payments from pharmaceutical and medical device companies, with $355.60 received in 2023. These payments were reported across 96 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,710).
As a Medicare-enrolled provider, Gaupp has provided services to 1,154 Medicare beneficiaries, totaling 2,589 services with total Medicare billing of $171,016. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Thomasville, GA
- Active Since 09/17/2005
- Last Updated 09/17/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1649265430
Products in Payments
- Spin (Device) $198.12
- KEYTRUDA (Biological) $145.31
- Neulasta (Biological) $92.70
- Optune (Device) $82.36
- KISQALI (Drug) $76.72
- LIBTAYO (Biological) $58.25
- ELIQUIS (Drug) $51.50
- NINLARO (Drug) $50.65
- JEVTANA (Drug) $47.86
- Trodelvy (Drug) $45.95
- LUMAKRAS (Drug) $45.34
- EMPLICITI (Biological) $33.36
- DARZALEX (Biological) $33.20
- MEKINIST (Drug) $29.80
- VOTRIENT (Drug) $26.08
- BOSULIF (Drug) $23.08
- ULTOMIRIS (Drug) $22.50
- RYBREVANT (Drug) $20.73
- Kyprolis (Drug) $20.13
- PRECISETUMOR (Device) $19.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.